J B Chemicals and Pharmaceuticals Ltd

Common Name
JB Pharma
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
5,304
Ticker
JBCHEPHARM
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
J.B. Chemicals & Pharmaceuticals Ltd. is a prominent pharmaceutical company with a focus on manufacturing high-quality pharmaceutical formulations and specialty chemicals. This company is recognized f...

JB Pharma's Financial Statements Preview

Below are the financial statements of JB Pharma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of INR
2024 as of 2024-03-31
2023 as of 2023-03-31
Assets
Non-current assets
Property, plant and equipment
5,468.34a
5,033.9a
Right-of-use assets
247.27a
286.23a
Capital work-in-progress
633.22a
444.09a
Goodwill
574.59a
574.59a
Intangible assets
13,753.77a
13,115.38a
Intangible assets under development
130.77a
107.43a
Financial assets
Investments
237.08a
137.84a
Loans
5.8a
6.84a
Other financial assets
99.75a
186.06a
Deferred tax assets (net)
58.78a
65.1a
Current tax assets (net)
149.98a
267.21a
Other non-current assets
48.47a
33.7a
Total non-current assets
21,407.82a
20,258.38a
Current assets
Inventories
5,025.13a
4,304.84a
Financial assets
Investments
3,646.5a
1,921.85a
Trade receivables
6,869.19a
5,758a
Cash and cash equivalents
882.15a
769.34a
Bank balances other than cash and cash equivalents
73.23a
18.78a
Loans
6.96a
13.74a
Other financial assets
127.23a
218.65a
Other current assets
1,903.06a
2,275.13a
Total current assets
18,533.45a
15,280.33a
Total assets
39,941.27a
35,538.71a
Equity
Equity share capital
155.2a
154.76a
Other equity
29,078.1a
24,648.77a
Equity attributable to the owners of the parent
29,233.29a
24,803.52a
Non-controlling interest
0a
0a
Total equity
29,233.29a
24,803.52a
Liabilities
Non-current liabilities
Financial liabilities
Borrowings
236.39a
3,832.2a
Lease liabilities
96.38a
153.21a
Provisions
183.88a
152.11a
Deferred tax liabilities (net)
1,492.08a
1,028.24a
Other non-current liabilities
16.99a
24.93a
Total non-current liabilities
2,025.72a
5,190.69a
Current liabilities
Financial liabilities
Borrowings
3,335.02a
1,650.18a
Lease liabilities
108.77a
88.87a
Trade payables
Total outstanding dues of micro enterprises and small enterprises
182.61a
215.34a
Total outstanding dues of creditors other than micro enterprises and small enterprises
3,380.5a
2,171.14a
Other financial liabilities
825.15a
707.92a
Other current liabilities
242.01a
236.51a
Provisions
490.59a
425.01a
Current tax liabilities (net)
117.62a
49.54a
Total current liabilities
8,682.26a
5,544.49a
Total liabilities
10,707.98a
10,735.18a
Total equity and liabilities
39,941.27a
35,538.71a
Download Data

Verified Sources Behind JB Pharma’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore JB Pharma’s data sources below and access millions more through our Disclosure Search.

a. JB Pharma's Annual Report 2024
a. JB Pharma's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?